Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine (ACh) release at cholinergic nerve terminals is a fundamental process in both the central and peripheral nervous systems, mediating neuromuscular transmission, autonomic ganglionic signaling, and many central nervous system functions. The process involves ACh synthesis by choline acetyltransferase, vesicular storage, calcium-dependent exocytosis triggered by action potentials, binding to nicotinic or muscarinic receptors (including autoreceptors), signal termination via acetylcholinesterase, and choline reuptake. Modulation of this process is a target for drugs affecting muscle contraction, autonomic regulation, and cognitive function, but can lead to cholinergic crisis or anticholinergic side effects. Degeneration of cholinergic neurons and impaired ACh release contribute to diseases like Alzheimer's disease.
Modulation of acetylcholine synthesis, storage, release, or degradation at cholinergic nerve terminals
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Release at Cholinergic Nerve Terminals (ACh Release).